GLP-1 and GLP-1/GIP agonists in psoriasis: A real-world cohort study on healthcare resource usage.

Hill MA, Treichel A, Cooper KD

Open source

DOI
10.1111/jdv.70678
Published
2026 Aug 21
Container
Journal of the European Academy of Dermatology and Venereology : JEADV
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jdv.70678,
  title = {GLP-1 and GLP-1/GIP agonists in psoriasis: A real-world cohort study on healthcare resource usage.},
  author = {Hill MA and Treichel A and Cooper KD},
  year = {2026},
  journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
  doi = {10.1111/jdv.70678},
  url = {https://doi.org/10.1111/jdv.70678}
}

RIS

TY  - JOUR
TI  - GLP-1 and GLP-1/GIP agonists in psoriasis: A real-world cohort study on healthcare resource usage.
AU  - Hill MA
AU  - Treichel A
AU  - Cooper KD
PY  - 2026
JO  - Journal of the European Academy of Dermatology and Venereology : JEADV
DO  - 10.1111/jdv.70678
UR  - https://doi.org/10.1111/jdv.70678
ER  - 

APA

MA, H., A, T., & KD, C. (2026). GLP-1 and GLP-1/GIP agonists in psoriasis: A real-world cohort study on healthcare resource usage.. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.70678

Source records